Detalhe da pesquisa
1.
A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease.
Blood
; 137(7): 896-907, 2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32976576
2.
The clinical landscape of chronic graft-versus-host disease management in 2021.
Br J Haematol
; 196(4): 830-848, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34599519
3.
The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma.
Br J Haematol
; 195(3): 405-412, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34500492
4.
Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemia.
Br J Haematol
; 188(6): 881-887, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31804722
5.
W"H-Y" antigen/HLA complexes in chronic GVHD.
Blood
; 142(11): 946-948, 2023 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37707875
6.
Clinical characteristics and cytokine biomarkers in patients with chronic graft-vs-host disease persisting seven or more years after diagnosis.
Am J Hematol
; 95(4): 387-394, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31903638
7.
Toxoplasma-induced hemophagocytic lymphohistiocytosis after haploidentical allogeneic stem cell transplantation.
Transpl Infect Dis
; 22(2): e13242, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31895492
8.
Red cell distribution width as a new prognostic biomarker in refractory chronic graft-versus-host disease.
Haematologica
; 109(1): 298-302, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37584292
9.
Relapsed Philadelphia Chromosome-Positive Pre-B-ALL after CD19-Directed CAR-T Cell Therapy Successfully Treated with Combination of Blinatumomab and Ponatinib.
Acta Haematol
; 141(2): 107-110, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30695783
10.
CAR T-cell therapy for indolent lymphoma: a new treatment paradigm?
Lancet Oncol
; 23(1): 6-8, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34895488
11.
Severe dysautonomia as a manifestation of neurotoxicity after CAR-T cell therapy for diffuse large B-cell lymphoma.
Am J Hematol
; 95(6): E146-E148, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32233094
12.
Genomics trumps clinical criteria in BMT? Nyet!
Blood
; 129(17): 2335-2336, 2017 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28450570
13.
Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumab.
Am J Hematol
; 94(8): E216-E219, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31120638
14.
High-dose Alemtuzumab-Cyclosporine vs Tacrolimus-Methotrexate-Sirolimus for Chronic Graft-versus-Host Disease Prevention.
Blood Adv
; 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38669315
15.
Incidence and Outcomes of Cytomegalovirus Reactivation after Chimeric Antigen Receptor T Cell Therapy.
Blood Adv
; 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38838226
16.
Sickle Cell Disease Complicated by Iron Overload: An Under-Recognized Risk Factor for Vibrio vulnificus Infection.
Acta Haematol
; 139(3): 199-200, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29734168
17.
Immunopathogenic mechanisms and modulatory approaches to graft-versus-host disease prevention in acute myeloid leukaemia.
Best Pract Res Clin Haematol
; 36(2): 101475, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37353287
18.
Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host disease.
Bone Marrow Transplant
; 58(10): 1112-1120, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37474729
19.
Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host disease.
Bone Marrow Transplant
; 58(12): 1377-1383, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37684526
20.
Chronic graft-versus-host disease is characterized by high levels and distinctive tissue-of-origin patterns of cell-free DNA.
iScience
; 26(11): 108160, 2023 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38026221